ERBB3 and breast carcinoma: Given the altered metabolic phenotype of HER2/neu-positive breast cancer cells, which rely on active fatty acid synthesis for survival [6, 7], it is possible that exogenous palmitate induces ER stress and decreases HER2/HER3 protein levels indirectly by interfering with FA synthesis.